Bad Blood
Secrets and Lies in a Silicon Valley Startup
First edition
Our rough guess is there are 84,750 words in this book.
At a pace averaging 250 words per minute, this book will take 5 hours and 39 minutes to read. With a half hour per day, this will take 12 days to read.
How long will it take you?
This book will take an estimated to read at a reading speed averaging words per minute. With 30 minutes per day, this will take to read.
Enter your reading speedYou can take one of our WPM reading speed tests to find your reading speed.
Create a free account to track your reading progress, build your reading list, and set reading goals.
Word Count
84,750 words, Guess
Page Count
339 pages
Physical Format
Hardcover
Identifiers
- Internet Archivebadbloodsecretsl0000carr_j4l5
- ISBN-10152473165X
- ISBN-139781524731656
- Goodreads61047137
- Library of Congress Control Number2018000263
and 4 more
- OCLC Control Number1249975944
- OCLC Control Number1029779381
- OCLC Control Number1030992480
- Open LibraryOL26470511M
Classifications
- DDC338.7/681761
- LCCHD9995.H423 U627 2018
- LCCHD9995.H423 U627 2020
Description
Bad Blood: Secrets and Lies in a Silicon Valley Startup is a nonfiction book by journalist John Carreyrou, released May 21, 2018. It covers the rise and fall of Theranos, the multibillion-dollar biotech startup headed by Elizabeth Holmes. The book received critical acclaim, winning the 2018 Financial Times and McKinsey Business Book of the Year Award.
Description
The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley.
Subjects
Topics
Places
People
Other Editions
- Bad Blood: Secrets and Lies in a Silicon Valley Startup
Show 12 more editions
2 other editions not shown
Reader Reviews
No reviews yet for this book.
Be the first to share your thoughts!